Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma

Cancer Gene Therapy, Published online: 20 June 2019; doi:10.1038/s41417-019-0112-zPhase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma

Source: Cancer Gene Therapy - June 19, 2019 Category: Cancer & Oncology Authors: Daniella E. Portal Robert E. Weiss Malgorzata Wojtowicz Amal Mansour Claude Monken Janice M. Mehnert Joseph A. Aisner Michael Kane Jennifer Nishioka Seena Aisner Stephen Peters Mark N. Stein Isaac Y. Kim Tina M. Mayer Weichung Shih James Gulley Howard Str Source Type: research